Evidence map›Paper›PMID 42385933›Full record

ArticleJournal of substance use and addiction treatment2026

How do services offered within opioid treatment programs vary based on state methadone policies?

Zoe Lindenfeld, Noa Krawczyk, Erin A Taylor, Denis Agniel, Jonathan H Cantor

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zoe LindenfeldEdward J. Bloustein School of Planning and Public Policy, Rutgers University, New Brunswick, NJ, 08901, USA. Electronic address: Zoe.Lindenfeld@Rutgers.edu.
Noa KrawczykCenter for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
Erin A TaylorRAND, 1776 Main Street, m5159, Santa Monica, CA, 90401, USA.
Denis AgnielRAND, 1776 Main Street, m5159, Santa Monica, CA, 90401, USA.
Jonathan H CantorRAND, 1776 Main Street, m5159, Santa Monica, CA, 90401, USA.

Funding

Access to Medications to Treat Opioid Use Disorder in the Medicare PopulationR01AG088646 · NIA · RAND CORPORATION · PI CANTOR, JONATHAN, TAYLOR, ERIN A · 2025 to 2025
$683k
NIA NIH HHS R01 AG088646
6 · The paper itself

Abstract

introductionState regulations governing opioid treatment programs (OTPs) vary widely in their restrictiveness, yet how state policies relate to the availability of services offered within OTPs remains understudied. In this study, we compare the availability of medication for opioid use disorder (MOUD) options, psychosocial services, and housing supports across OTPs operating in states with different levels of OTP policy restrictions.

methodsWe conducted a cross-sectional study of 1501 opioid treatment programs (OTPs) in the United States. Exposures included 11 state-level OTP policies that impose legal or administrative barriers to opening or operating OTPs or to patients' receipt of care (e.g., pharmacy licensure requirements, zoning restrictions, government identification requirements, and administrative discharge for positive drug screenings). Data on OTP service offerings-including buprenorphine, naltrexone, all three medications for opioid use disorder, mental health services, contingency management, trauma-informed counseling, and housing services-and organizational characteristics were obtained from the 2023 Mental Health and Addiction Treatment Tracking Repository, a national longitudinal database of licensed substance use disorder treatment facilities. These data were linked to a previously developed state policy typology using latent class analysis, which categorized states as having low or high OTP restrictiveness. Regression models adjusted for state- and organizational-level characteristics and accounted for clustering within states.

resultsIn descriptive analyses, OTPs in highly restrictive states were significantly less likely (p < 0.05) to offer all three MOUDs and behavioral health services, including mental health services, trauma-informed counseling, and contingency management, compared with OTPs in low-restrictiveness states. In adjusted Poisson regression models, facilities in highly restrictive states were significantly less likely to offer naltrexone (ARR: 0.73; 95% CI: 0.54-0.97) and all three MOUDs (ARR: 0.70; 95% CI: 0.53-0.92).

conclusionsGiven that OTPs are the only facilities in which methadone can be legally dispensed, these facilities are a critical point of access for individuals in need of evidence-based OUD treatment. However, our findings suggest that states that place additional restrictions on OTPs also offer less services within their OTPs.

Indexed as

Health PolicyHealth Services AccessibilityMethadoneOpiate Substitution TreatmentOpioid-Related DisordersSubstance Abuse Treatment CentersBuprenorphineCross-Sectional StudiesHumansMental Health ServicesNaltrexoneState GovernmentUnited StatesBuprenorphineMethadoneNaltrexoneBuprenorphineHealth policyHealth services researchMethadoneOpioid treatment programsOpioid use disorder

Identifiers

PMID42385933
PMCPMC13386141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.